Imad Tleyjeh

7PUBLICATIONS
12CO-AUTHORS
Preventative health careMajor global burdens of diseaseMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 03, 2022
Sotrovimab Lowers the Risk of COVID-19 Related Hospitalization or Death in a Large Population Cohort in the United Arab Emirates.

Fatemeh Saheb Sharif-Askari, Hawra Ali Hussain Alsayed, Imad Tleyjeh

|Aug 11, 2021
Overlooked Shortcomings of Observational Studies of Interventions in Coronavirus Disease 2019: An Illustrated Review for the Clinician.

Imad M Tleyjeh, Tarek Kashour, Jay Mandrekar

|Jul 14, 2021
Prior Statin Use and Risk of Mortality and Severe Disease From Coronavirus Disease 2019: A Systematic Review and Meta-analysis.

Zachary A Yetmar, Supavit Chesdachai, Tarek Kashour

|Jun 10, 2021
Combination of (interferon beta-1b, lopinavir/ritonavir and ribavirin) versus favipiravir in hospitalized patients with non-critical COVID-19: A cohort study.

Areej A Malhani, Mushira A Enani, Fatemeh Saheb Sharif-Askari

|Jan 12, 2021
Letter About: Risk Factors for Mortality in Patients with COVID-19 in New York City.

Imad M Tleyjeh, Tarek Kashour

|Jan 07, 2021
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility.

Tarek Kashour, Rabih Halwani, Yaseen M Arabi

Pageof 2

Frequent Collaborators

2 joint publications

Tarek Kashour

1 joint publications

Tarek Kashour

1 joint publications

Zachary A Yetmar

1 joint publications

Supavit Chesdachai